Patients with locally advanced esophageal carcinoma nonresponder to radiochemotherapy: who will benefit from surgery?

Ann Surg Oncol. 2007 Jul;14(7):2036-44. doi: 10.1245/s10434-007-9405-9. Epub 2007 Apr 24.

Abstract

Background: In patients who are nonresponders to primary radiochemotherapy (RCT), prognosis is poor, leading mostly to palliation. Salvage surgery may have a survival benefit otherwise complete. Our aim was to identify predictors of R0 resection in these patients.

Methods: In 98 nonresponders with locally advanced infracarinal tumors, curative salvage surgery was attempted. Resection was R0 in 62.2% and incomplete in 37.8% of cases. Univariate and multivariate analyses included pre-RCT and post-RCT variables collected prospectively.

Results: Overall survival was higher in the R0 resection group (18.4 vs 8.6 months, P < .001). Independent predictors of R0 resection were tumor height <or= 5 cm on barium swallow (P = .045) and aortic contact <or= 90 degrees on computed tomography (P = .039) evaluated after RCT. Three groups of patients were constructed: 1, tumor height <or= 5 cm with aortic contact <or= 90 degrees (n = 43); 2, tumor height between 6 and 10 cm with aortic contact <or= 90 degrees (n = 32); and 3, aortic contact > 90 degrees , irrespective of tumor height (n = 23). Rates of R0 resection were 81%, 53%, and 39%, respectively (P = .001).

Conclusion: Salvage esophagectomy should be systematically attempted in nonresponders with tumor height <or= 5 cm on barium swallow and aortic contact <or= 90 degrees on computed tomography and discussed case by case for other patients.

MeSH terms

  • Adenocarcinoma / diagnosis
  • Adenocarcinoma / mortality
  • Adenocarcinoma / surgery*
  • Adenocarcinoma / therapy
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Carcinoma, Squamous Cell / mortality
  • Carcinoma, Squamous Cell / pathology
  • Carcinoma, Squamous Cell / surgery*
  • Carcinoma, Squamous Cell / therapy
  • Cisplatin / therapeutic use
  • Combined Modality Therapy
  • Databases as Topic
  • Esophageal Neoplasms / diagnosis
  • Esophageal Neoplasms / mortality
  • Esophageal Neoplasms / surgery*
  • Esophageal Neoplasms / therapy
  • Esophagectomy
  • Fluorouracil / therapeutic use
  • Humans
  • Middle Aged
  • Neoadjuvant Therapy
  • Prognosis
  • Radiotherapy, Adjuvant
  • Retrospective Studies
  • Salvage Therapy
  • Survival Analysis
  • Treatment Failure
  • Treatment Outcome

Substances

  • Cisplatin
  • Fluorouracil